Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
Takahide Nakazawa(Kitasato University Hospital), Wasaburo Koizumi(Kitasato University), Shigehiro Kokubu, Tsutomu Minamino(Kitasato University), Akitaka Shibuya, Masaaki Watanabe(Kitasato University), Juichi Takada(Kitasato University), Hisashi Hidaka(Kitasato University), Yusuke Okuwaki(Kitasato University), Yoshiaki Tanaka(Jichi Medical University)
Cited by 132
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513
MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.
|The EMBO Journal|1992|481